Understanding Drug Interactions Quiz

What is the term used to describe a drug interaction where one drug increases the effect of another drug beyond what either drug would produce alone?

• Antagonism

• Synergism

• Tolerance

• Tachyphylaxis

Which type of drug interaction occurs when one drug affects the absorption, distribution, metabolism, or excretion of another drug?

• Pharmacodynamic interaction

• Chemical interaction

• Pharmacokinetic interaction

• Idiosyncratic interaction

Which enzyme system in the liver is most commonly responsible for pharmacokinetic drug interactions involving drug metabolism?

• Monoamine oxidase (MAO)

• Cytochrome P450 (CYP450)

• Acetylcholinesterase

• Xanthine oxidase

A patient is taking warfarin (an anticoagulant) and is prescribed rifampicin (an antibiotic). Rifampicin is a known CYP450 enzyme inducer. What is the most likely effect of this drug interaction on warfarin's efficacy?

• Warfarin levels will increase, raising the risk of bleeding

• Warfarin levels will decrease, reducing its anticoagulant effect

• Warfarin will be converted into a toxic metabolite

• Warfarin's protein binding will increase, enhancing its effect

A patient taking an ACE inhibitor for hypertension is also prescribed a potassium-sparing diuretic. Which of the following best describes the pharmacodynamic mechanism of the interaction between these two drugs?

• The diuretic inhibits the metabolism of the ACE inhibitor

• Both drugs independently reduce potassium excretion, leading to additive hyperkalemia

• The ACE inhibitor increases the renal clearance of the diuretic

• The diuretic displaces the ACE inhibitor from plasma protein binding sites

Which of the following best describes an antagonistic drug interaction?

• Two drugs produce a combined effect greater than the sum of their individual effects

• One drug reduces or nullifies the effect of another drug

• Two drugs produce effects equal to the sum of their individual effects

• One drug accelerates the absorption of another drug

A patient on selective serotonin reuptake inhibitors (SSRIs) is inadvertently prescribed a monoamine oxidase inhibitor (MAOI). Applying your knowledge of drug interaction mechanisms, what serious condition could result from this combination and why?

• Neuroleptic malignant syndrome, due to dopamine receptor blockade

• Serotonin syndrome, due to excessive serotonergic activity from inhibition of both serotonin reuptake and serotonin breakdown

• Anticholinergic toxidrome, due to combined muscarinic receptor blockade

• Agranulocytosis, due to additive bone marrow suppression

A 65-year-old patient with multiple comorbidities is on digoxin for heart failure and is started on amiodarone for arrhythmia. Amiodarone inhibits P-glycoprotein and CYP450 enzymes. Critically analyze the potential consequences of this interaction and recommend an appropriate clinical management strategy.

• Digoxin levels will decrease; increase the digoxin dose to maintain therapeutic effect

• Digoxin levels will increase due to reduced clearance and efflux; reduce the digoxin dose and monitor serum digoxin levels closely

• Amiodarone will be rapidly eliminated; switch to a different antiarrhythmic agent

• No significant interaction exists; continue both drugs at the same doses without monitoring

A pharmacist is reviewing a patient's medication list and identifies a potentially dangerous drug interaction. The patient is taking methotrexate (a drug with a narrow therapeutic index) along with NSAIDs. Using your understanding of drug interaction mechanisms, evaluate why this combination is clinically significant and what preventive measure should be taken.

• NSAIDs induce CYP450 enzymes, increasing methotrexate metabolism and reducing its efficacy; switch to acetaminophen for pain relief

• NSAIDs reduce renal blood flow and compete for tubular secretion, leading to increased methotrexate levels and toxicity; avoid concurrent use or monitor renal function and methotrexate levels closely

• NSAIDs enhance methotrexate absorption from the gastrointestinal tract, causing supratherapeutic levels; administer both drugs at separate times of the day

• NSAIDs displace methotrexate from tissue binding sites, reducing its therapeutic effect; increase the methotrexate dose accordingly

Which of the following strategies is most effective in preventing clinically significant drug interactions in a patient receiving polypharmacy?

• Administering all medications simultaneously to simplify the regimen

• Conducting regular medication reconciliation and using drug interaction screening tools

• Avoiding the use of generic drug formulations

• Limiting the patient's fluid intake to reduce drug distribution